Diisopropylethylamine → HCID 69287829, compound
Reaction equation
[C:1]([C:5]1[S:9][C:8]([NH2:10])=[N:7][N:6]=1)([CH3:4])([CH3:3])[CH3:2].[Li].[CH2:12]([O:19][C:20]([NH:22][CH2:23][C@H:24]([NH:30][C:31](=[O:36])[CH2:32][C:33](O)=[O:34])[C@@H:25]([OH:29])[C:26]#[C:27][CH3:28])=[O:21])[C:13]1[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=1.C(N(CC)C(C)C)(C)C.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>C(Cl)Cl.CN(C=O)C>[CH2:12]([O:19][C:20](=[O:21])[NH:22][CH2:23][C@H:24]([NH:30][C:31](=[O:36])[CH2:32][C:33](=[O:34])[NH:10][C:8]1[S:9][C:5]([C:1]([CH3:4])([CH3:3])[CH3:2])=[N:6][N:7]=1)[C@@H:25]([OH:29])[C:26]#[C:27][CH3:28])[C:13]1[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
The compound 5-tert-butyl-[1,3,4]thiadiazol-2-ylamine (67 mg, 0.43 mmol) was dissolved in 6 mL of 1:1 CH2Cl2/DMF. The resultant solution was charged sequentially with the lithium salt of N-[(1S,2S)-1-(benzyloxycarbonylamino-methyl)-2-hydroxy-pent-3-ynyl]-malonamic acid (151 mg, 0.43 mmol, see procedure 21a), N, N-diisopropylethylamine (0.38 mL, 2.1 mmol) and HATU (194 mg, 0.51 mmol). The mixture was stirred for 12 h at RT, concentrated in vacuo, and partitioned between EtOAc and sat. NH4Cl. The aqueous phase was extracted with EtOAc (1×). The combined organic extracts were washed with sat. NaHCO3 and brine, dried (Na2SO4), filtered, and concentrated in vacuo. The residue was purified by flash chromatography to afford {(2S,3S)-2-[2-(5-tert-butyl-[1,3,4]thiadiazol-2-ylcarbamoyl)-acetylamino]-3-hydroxy-hex-4-ynyl}-carbamic acid benzyl ester as a colorless oil (90 mg, 43% yield). MS found: (M+Na)+=510.4.
Workup
- concentrationconcentrated in vacuo
- custompartitioned between EtOAc and sat. NH4Cl
- extractionThe aqueous phase was extracted with EtOAc (1×)
- washThe combined organic extracts were washed with sat. NaHCO3 and brine
- dry with materialdried (Na2SO4)
- filtrationfiltered
- concentrationconcentrated in vacuo
- customThe residue was purified by flash chromatography
Sources & evidence
- ORD record
- ord-be8f2d854c7140c4a480a10d4d6516ea
- Source dataset
- uspto-grants-2007_06
- Patent number
- US07230133B2
Reaction notes
Loading…